Amalgamated Financial’s Amgen AMGN Stock Holding History

Amalgamated Financial’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$38M	Buy	+157,007	New	+$36.1M	0.3%	54

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Amalgamated Financial's AMGN Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Amgen (AMGN) in Q1 2022: 157,007 shares worth $38M. The stake represents 0.3% of the portfolio and ranks #54 among its holdings.

2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

Amalgamated Financial held 157,007 shares of Amgen worth $38M as of Q1 2022.
Amgen was a new Amalgamated Financial position in Q1 2022.
Amgen made up 0.3% of Amalgamated Financial's portfolio in Q1 2022, its #54 holding.
2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.